Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
181658 Clinical Research Fellow in Translational Myeloma Research Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Grade E63 or E64: £36,616 - £70,425 per
-
We are inviting applications for an exciting new post for a Research Assistant to work with Dr Megan Kirk Chang on an interdisciplinary research program on the Oxford Health BRC Preventing Multiple
-
Machine Learning, Statistics, Computer Science or closely related discipline. They will demonstrate an ability to publish, including the ability to produce high-quality academic writing. They will have the
-
The Oxford Applied and Theoretical Machine Learning group at the Department of Computer Science has a new opening for a Project Support Officer, working together with Professor Yarin Gal. In
-
180619 – Research Assistant Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Grade 6: £34,982-£40,855 per annum This is a full time, fixed term position for 30
-
to scientific colleagues. Support the senior team in designing an internal funding programme for translational research projects to de-risk technology development. Manage the administrative activities related
-
, and the wider MSc Taught Programmes Team. To be successful in this role, you will need to be highly organised, have previous administrative experience, and demonstrate strong computer skills. A positive
-
(or have recently submitted) in a relevant subject (climate, meteorology, physical geography, earth and environmental sciences, physics and astronomy, applied mathematics, statistics, computer science
-
We have a new and exciting opportunity for a Postdoctoral Research Scientist to join the Pandemic Science Institute’s (PSI) growing efforts in computational vaccinology and vaccine trial design. You
-
—an internationally recognised leader in vaccinology—at the Oxford Vaccine Group and the Pandemic Sciences Institute. You will lead a cutting-edge research programme focused on mucosal vaccine technologies targeting